Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Sevelamer Carbonate on Critical Variables in the Pathogenesis of Secondary Hyperparathyroidism

NCT01191762 is registered in ClinicalTrials.gov with Kenneth R. Phelps, M.D. as lead sponsor.

NCT NCT01191762
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01191762 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Sevelamer Carbonate on Critical Variables in the Pathogenesis of Secondary Hyperparathyroidism
Lead sponsor
Kenneth R. Phelps, M.D.
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2010
Completion date
April 30, 2013
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, hyperparathyroidism